Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

US adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford’s Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.

Doctor measuring blood pressure © Shutterstock

The study compared health measures such as smoking habits, weight, cholesterol levels, and blood pressure among US and British adults aged 33 to 46. It found that North American adults have worse cardiovascular health and higher levels of obesity than their British counterparts, along with greater disparities in health by socioeconomic factors. For several outcomes, including hypertension, high cholesterol, and obesity, even the most socioeconomically advantaged groups in the US had similar or worse health than the most disadvantaged groups in Britain. On the other hand, British adults rated their overall health worse on average and were more likely to smoke.

Co-author Professor Jennifer Dowd, Deputy Director of the Leverhulme Centre for Demographic Science and Oxford Population Health’s Demographic Science Unit said, ‘Despite the worse health of North American compared to British adults in midlife, higher rates of smoking and growing obesity levels in Britain show that there is room for improvement in both countries. Worsening health trends in the US could serve as a warning for Britain and the need to focus on prevention and the broad social determinants of health.’

The study, co-authored by researchers at University College London’s (UCL) Centre for Longitudinal Studies, Syracuse University and University of North Carolina, compared data from the 1970 British Cohort Study in Britain and the Add Health study in the US. The analysis included data from almost 10,000 British people born in 1970 and 5,000 American adults born between 1976 to 1983. Participant’s blood pressure, cholesterol levels, Body Mass Index (BMI) and glucose were measured, and they also self-reported their smoking habits and quality of health.

Read the full story on the University of Oxford website.

 

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.